Trypanosoma rangeli: a new perspective for studying the modulation of immune reactions of Rhodnius prolixus

  • Eloi S Garcia1Email author,

    Affiliated with

    • Daniele P Castro1,

      Affiliated with

      • Marcela B Figueiredo1,

        Affiliated with

        • Fernando A Genta1 and

          Affiliated with

          • Patrícia Azambuja1

            Affiliated with

            Parasites & Vectors20092:33

            DOI: 10.1186/1756-3305-2-33

            Received: 22 June 2009

            Accepted: 17 July 2009

            Published: 17 July 2009


            Insects are exposed to a wide range of microorganisms (bacteria, fungi, parasites and viruses) and have interconnected powerful immune reactions. Although insects lack an acquired immune system they have well-developed innate immune defences that allow a general and rapid response to infectious agents.

            Over the last few decades we have observed a dramatic increase in the knowledge of insect innate immunity, which relies on both humoral and cellular responses. However, innate reactions to natural insect pathogens and insect-transmitted pathogens, such as parasites, still remain poorly understood.

            In this review, we briefly introduce the general immune system of insects and highlight our current knowledge of these reactions focusing on the interactions of Trypanosoma rangeli with Rhodnius prolixus, an important model for innate immunity investigation.


            The insect innate immune reactions

            There are two types of innate immune reactions: (i) the humoral response that is related to antimicrobial peptides, lectins and the prophenoloxidase (PPO) cascade and (ii) the cellular response which includes phagocytosis, hemocytes aggregation and encapsulation of pathogens.

            Innate immunity of insects relies on a limited variety of receptors which recognize specific compounds that are on the surface of microorganisms or are released by them. The most well known pathogen-associated molecular patterns (PAMPs) are microbial cell-wall components like lipopolysaccharides (LPS) of Gram-negative bacteria, lipoteichoic acid and peptidoglycans of Gram-positive bacteria, β-1,3 glucans from fungi as well as glycosylphosphatidylinositol (GPI) from protozoan parasites [1, 2].

            The humoral immune system recognizes PAMPs by pattern recognition receptors which are conserved in evolution to bind unique products of microbial metabolism not produced by the host [1, 2]. The humoral pattern recognition receptors such as LPS-binding proteins, peptidoglycan recognition proteins (PGRPs), Gram-negative binding proteins (GNBPs), β1,3-glucans recognition protein (βGRP), circulates in the hemolymph of insects [3, 4].

            In the hemocyte surface there are several proteins implicated in the cellular immune response against invading microbes by recognizing the PAMPs. The most well known cellular receptors involved in recognition of pathogens in several insect species are croquemort (homologue of the mammalian CD36 family), Down syndrome cell-adhesion molecule (Dscam), peptidoglycan recognition protein (PGRP-LC), Eater (transmembrane protein) and the Toll family members [3, 4].

            Humoral immunity

            Drosophila melanogaster, a dipteran, has become an appropriate model for the investigation of immune pathways and insect-microorganism interactions [46]. Apparently, the main components of the core signaling processes are conserved between insects [4]. The genome sequencing of these insects allowed a comparative genomic analysis of the gene families involved in the Drosophila defence reactions [7]. The best-characterized insect humoral response is the production of antimicrobial peptides (AMPs). These peptides are small, cationic and with different structures. They are released into the hemolymph during infection [8]. The main source of AMPs is from the fat body, but several epithelia and insect organs are also able to produce these substances [9]. The most important AMPs are defensins which act mainly against Gram-positive bacteria [10]. However, cecropins that have a large spectrum are more effective against Gram-negative bacteria [11]. There are other AMPs like attacin, diptericin, drosocin and drosomycin, etc [5, 12]. Most AMPs have simple and non-specific modes of antibiotic action, such as driving pathogen membrane disruption by altering the membrane permeabilization or through an intracellular target [1012].

            Investigation in Drosophila demonstrated that production of AMPs is related to two distinct pathways: Toll and IMD pathways [3]. Recent studies suggested that these two pathways respond respectively to Gram-positive or Gram-negative bacteria and fungal infections in insects [5, 12]. A third pathway involved in immune reactions, especially in mammals, is the JAK/STAT (Janus kinase/Signal transducer and activator of transcription) [13]. The JAK/STAT signaling pathway takes place mainly in the fat body of insects. The production of AMPs is a common result of JAK/STAT, Toll and Imd pathway activity [14] (Figure 1).
            Figure 1

            Toll, IMD and JAK-STAT pathways. Insect tissues recognize pathogen-associated molecular patterns (PAMPs) by transmembrane receptors (DOME, Toll and PGRPs) in plasmatic membrane (PM) that activate the three pathways. The JAK-STAT pathway is activated by the receptor DOME (domeless) that transduces the signal to JAK and the cytosolic STAT. The Toll pathway starts with activation of the receptor Toll that signals to the cleavage of Dorsal-related immunity factor (DIF) complex releasing DIF. The IMD pathway through peptidoglycan recognition proteins (PGRPs) activates IMD (immune deficiency) that regulates the proteolytic cleavage and activation of Relish. The transcription factors (STAT, DIF and Relish) translocate to the nucleus through the nuclear membrine activating the expression of its transcriptional targets resulting in the production of antimicrobial peptides and other immune responses.

            The prophenoloxidase (PPO) cascade, which leads to melanization and production of highly reactive and toxic compounds (e.g. quinones), is another important humoral immune reaction in insects. Also, there are several papers reporting that phenoloxidase (PO) promotes cellular defence reaction like phagocytosis [for review see [15]]. Although in some cases, the melanization process is not important for clearing an infection, it is relevant for pathogen encapsulation [15]. Melanization depends on tyrosine metabolism. The PPO activation cascade is composed of several proteins, including PPO, serine proteases and their zymogens, as well as proteinase inhibitors. The PPO cascade is set off by the recognition of PAMPs that leads to the activation of a serine protease cascade culminating in the limited proteolytic cleavage of PPO to produce active PO that catalyzes the oxidation of tyrosine to dihydroxyphenylalanine (DOPA) which is subsequently oxidized to form dopaquinone and dopamine quinone as well as 5, 6-dihydroxyindole which have highly antibacterial activities (Figure 2). These compounds are precursors of the melanin polymer which is deposited on the surface of encapsulated parasites, hemocyte nodules and wound sites [13]. Besides the PPO activation cascade is regulated by plasma serine protease inhibitors (including members of the serpin superfamily) and active phenoloxidase (PO), this process being directly inhibited by proteinaceous factors [15, 16] (Figure 2). Such regulations are essential because the products of PO activity are potentially toxic to the host.
            Figure 2

            A serine proteinase cascade is activated when different receptors recognize pathogen-associated molecular patterns (PAMPs). These serine proteases hydrolyze and activate the prophenoloxidase-activating proteinase precursor (proPAP) to prophenoloxidase-activating proteinase (PAP) that can be inhibited by serpins (proteinase inhibitors). The enzyme PAP hydrolyses prophenoloxidase (PPO) releasing phenoloxidase (PO). PO oxidizes tyrosine to dihydroxyphenylalanine (DOPA) and subsequently into quinones, the precursors of melanin, cytotoxic products and encapsulation of pathogens.

            Finally, the mosquito Anopheles stephensi, a natural vector of human malaria, limits parasite development with inducible synthesis of nitric oxide (NO). Elevated expression of A. stephensi NO synthase (NOS) that is highly homologous to other characterized NOS genes, occurs in the midgut and carcass soon after invasion of the midgut by Plasmodium [17]. Interestingly, in the hemolymph the nitrite/nitrate ratios, and the products of NO synthesis are higher in Plasmodium-infected mosquitoes and the treatment with NOS inhibitor N-nitro-L-arginine methylester significantly increases the number of parasites in infected mosquitoes [17].

            Cellular reactions

            Insect cellular responses are mediated by circulating hemocytes, and they include phagocytosis, hemocytes aggregation and encapsulation. Insect phagocytosis refers to the process by which hemocytes recognize, internalize and destroy microorganismal invaders [18]. In Drosophila, phagocytosis is performed mainly by plasmatocytes, while hemocyte aggregation and encapsulation are carried out by lamellocytes that attach, embrace and inactivate the invading organisms, which then die by asphyxiation or by free radical attack [19]. Frequently, there is a local activation of the PPO cascade that cross-links the hemocyte aggregates and microorganisms in a melanin envelope.

            Eicosanoid pathways

            Eicosanoids are oxygenated metabolites of arachidonic acid with a huge range of physiological functions in a diversity of organisms. Among the important functions ascribed to eicosanoids are the central role that they play in the inflammatory and immune defence reactions in mammals [20] and the mediation of cellular defence responses to bacterial infections in insects [21]. In fact, results from over 20 insect species representing 5 orders indicated that eicosanoids mediate cellular immune reactions to bacterial infections [22]. Stanley-Samuelson et al. [23] demonstrated, for the first time, that eicosanoids regulate bacterial clearance from the insect's hemolymph. Following this pioneering paper, much research has been done on the relation of eicosanoids in regulating the insect immune system, especially on the elimination of inoculated bacteria from the hemolymph by nodule formation, the major cellular immune response to bacterial infections in insects [2124]. The decrease of arachidonic acid production due to dexamethasone effect on phospholipase A2 (PLA2) activity reflects on the products of the cyclooxygenase (COX) and lipoxygenase (LOX) pathways, diminishing both bacteria clearance [23] and nodulation [24] in insects. After that, the recognition of the biological significance of eicosanoids in signal transduction in insect immune responses rapidly increased [21] with studies of insects infected with bacteria and fungi [2527], parasitoids [28], protozoa [29, 30] and viruses [31, 32].

            Miller and Stanley [33] have shown that eicosanoid biosynthesis inhibitors have a direct effect on Manduca sexta hemocytes and Tunaz et al. [34] demonstrated that dexamethasone exerts its effect on insects by inhibiting PLA2. Investigations made by Mandato et al. [25] showed that eicosanoid biosynthesis inhibitors attenuated the PO activity in Galleria mellonella challenged with bacteria, and this inhibitory effect of dexamethasone was abolished by the addition of arachidonic acid (Figure 3). So, many models of insect species have been studied to expand and generalize the hypothesis that eicosanoids mediate the nodule formation in insect hemolymph during immune responses to bacterial, fungal, parasitoid and viral infections.
            Figure 3

            Phospholipids are hydrolyzed by phospholipase A 2 liberating arachidonic acid and Lyso-PAF, regulators of insect's immune system. Arachidonic acid is the substrate for eicosanoid production, prostaglandins via cyclooxygenase and leukotrienes via lipoxygenase. Lyso-PAF is acetylated by PAF-acetyl transferase releasing PAF that can be degraded by PAF-acetyl hydrolase that hydrolyses PAF regenerating Lyso-PAF. In the presence of dexamethasone the immune responses are inhibited due to the suppression of phospholipase A2 activity with lower production of eicosanoids and PAF. On the other hand when exogenous arachidonic acid is added there is enhancement of eicosanoid production and immune responses increase.

            Some invading microorganisms induce an immunological depression to avoid the immune reactions of insects. The entomopathogenic bacterium, Xenorhabdus nematophila, induces immunodepression in target insects by (PLA2) activity inhibition causing lethal septicemia of the infected hosts [3537].

            The Trypanosoma rangeli model

            Trypanosomes are digenetic parasites that have insects as vectors and infect human beings and other vertebrates as hosts [38]. So far, only species of the genus Rhodnius have presented infective forms of Trypanosoma rangeli in their salivary glands [39]. In Latin America, this parasite has two major lineages based on kinetoplast DNA (kDNA) markers: one group presents three types of kDNA minicircles (KP1, KP2 and KP3- T. rangeli KP1+), while the other group has only KP2 and KP3 minicircles (T. rangeli KP1-) [for review [40]]. T. rangeli is a harmless parasite for humans and various wild and domestic animals, but it can be pathogenic to the insect vector [40].

            While the full biological cycle of Trypanosoma cruzi, the causative agent of Chagas disease, takes place in the guts of the triatomine vectors, and the infecting parasites are eliminated with feces and urine to contaminate vertebrate hosts [4144], the T. rangeli life cycle in the vector is different. The vector infection begins when parasitesare ingested as trypomastigote forms. The parasites multiply as epimastigotes in the gut, and they are able to penetrate through the gut epithelium [45] (Figure 4) invading the hemocele. In the regular course of infection, a few days after parasite ingestion, short epimastigote forms appear in the insect hemolymph. Soon, they disappear to be replaced by a massive colonization by long epimastigotes [46]. The epimastigotes survive in the hemolymph and/or inside the hemocytes. Then, they migrate and possibly by recognition of carbohydrate moieties attach to salivary glands [47], invade them and complete their development into infective forms [4850] (Figure 4).
            Figure 4

            Scheme of biological cycle of Trypanosoma rangeli within its insect vector. The insect feeds on blood infected with trypomastigote forms which differentiate to epimastigotes in the midgut (white arrows) where they multiply (1). Some epimastigotes invade the hemolymph through the gut epithelium (red arrow). Long and short forms of epimastigotes can entry into the hemocytes and multiply or replicate in the plasma (2). Some parasites invade the salivary glands (blue arrow) and differentiate to trypomastigotes which will be transmitted when the insect-vector feeds on another host (3).

            Interestingly, Garcia et al. [50] described that T. rangeli impairs R. prolixus salivary gland function, preventing full expression of its antihemostatic machinery [51] prolonging the duration of intradermal probing.

            The Rhodnius prolixus model

            Rhodnius belongs to the subfamily Triatominae of the family Reduviidae that is made up of 140 species of triatomines, several of which are vectors or potential vectors of the hemoflagellate protozoan parasites T. cruzi and T. rangeli. However, only species of the genus Rhodnius have infective forms of T. rangeli in their salivary glands [48, 52].

            Since the main characteristic of the T. rangeli life cycle is the invasion of the insect hemocele it must overcome the immune reactions of its vector. We will therefore use the bloodsucking bug, Rhodnius prolixus, as a tool for providing insights into how insects defend themselves against infection by bacteria and parasites such as T. rangeli. From a practical point of view, R. prolixus has many advantages as an insect model for research on parasite transmission. These include simple maintenance and rearing in the laboratory and feeding through an artificial membrane device. This facilitates the infection with parasites and, due the body size, they are easily handled and manipulated [42, 53]. Besides that, R. prolixus is frequently used for physiological studies [54, 55] and, more recently, for biochemical and immunological investigations [44]. Nevertheless, there is a great lack of molecular data about the R. prolixus immune system, and the majority of studies focused in the cellular response or in the effects of the vector immune defences in the parasite development (and vice versa). However, the sequencing of its complete genome (670 MBp) [56] will facilitate the application of advanced molecular biology to enhance ongoing research for exploration of biomedical significance of this insect.

            Trypanosoma rangeli infection and Rhodnius prolixus immune reactions

            Knowledge on the Rhodnius immune system and its activation in response to microorganism infections has grown in recent years. The first defences against microbiological infections are the structural barriers outside or inside the body (for example, exoskeleton and the perimicrovillar membrane in the midgut [55, 5759].

            The establishment of T. rangeli infection in both gut and hemocele of the insect vector is possibly regulated by a range of biochemical and physiological processes. The first environment for the transformation and development of T. rangeli is in the gut. There the parasites are confronted with anterior and posterior midgut components and products of blood digestion. These included bacteria [60, 61], hemolytic factors [62] and lectins [46, 63], all of which may modulate the infection of T. rangeli in the vector gut.

            Once in the hemocele, T. rangeli must overcome the robust insect vector's defence system including lysozymes and trypanolytic activities [46], PPO activation [64], phagocytosis and hemocyte microaggregate formations [29, 30, 6567], agglutination [46, 63], superoxide and nitric oxide production [68] and a trypanolytic protein which acts specifically against the T. rangeli KP1-strains [40]. All these activities seem to act as biological barriers raising difficulties for the development and transmission of the parasite in the vector.

            Humoral reactions and T. rangeli infection

            Although Lopez et al. [69] showed that defensin was induced both in the hemolymph and midgut of R. prolixus by inoculation of Escherichia coli and Microccocus luteus, there are some data on the inactivation of the R. prolixus humoral immune system by parasite infection. Mello et al. [46] demonstrated that, after systemic inoculation of T. rangeli short epimastigotes into the hemocele of R. prolixus, the parasite produces a high intensity of infection through successive division during the extracellular development, with a concomitant increased levels in the lysozyme activity in the hemolymph. They also showed that T. rangeli infection induced neither trypanolytic nor peptide antibacterial activities, but a galactose-binding lectin from R. prolixus hemolymph, which enhanced the activation of clump formation by T. rangeli in R. prolixus hemocyte monolayers. An increase in clump size and hemocyte aggregation was also described [70]. This purified lectin also affected in vitro the motility and survival of T. rangeli culture short forms, but not the long forms [70], which are predominant in the hemolymph two days after inoculation [46].

            Another important biological event of T. rangeli interference in the insect immune reactions is its ability to activate the PPO system of R. prolixus. Gregorio and Ratcliffe [71, 72] demonstrated that Triatoma infestans, but not R. prolixus, presents a very active PPO system when activated by laminarin and lipopolysaccharides. For both species of insects, neither T. rangeli from culture nor parasite lysates were able to trigger PPO activation in vitro. However, the presence of the parasite in R. prolixus hemolymph assays reduced the level of PPO activation by laminarin. These authors suggest that the susceptibility of R. prolixus to T. rangeli hemolymph infection may, at least in part, be explained by the suppression of the inset immune defence system i.e. inhibition of the PPO cascade in the presence of this parasite.

            Interestingly, Gomes et al. [73] clearly demonstrated using in vitro experiments that the activation of the PPO pathway occurred when the hemolymph was incubated with fat body homogenates and short epimastigote forms of T. rangeli. The same authors using in vivo experiments showed that short, but not long, epimastigote forms activated directly the formation of melanin [73]. In addition, the PPO-activating pathway was suppressed when insects, which had been fed on blood containing either short or long epimastigotes, were challenged by thoracic inoculation of the short forms. This indicates that the reduction of the PO activity was a result of parasite ingestion. The PPO pathway is activated when glycosylphosphatidylinositol (GPI) anchors, specifically glycoinositolphospholipids (GIPLs) and GPI-mucins purified from T. rangeli epimastigotes, are inoculated in the insect [74].

            One factor that can be important for killing T. rangeli is nitric oxide and nitrite/nitrate radicals, products of NO synthase (NOS) activity. Whitten et al. [68] described experiments to demonstrate whether or not nitric oxide and superoxide production could operate during T. rangeli infection in R. prolixus. These authors followed the inoculation of two strains and two developmental forms of T. rangeli after 24 h. When the H14 strain was inoculated, the parasites failed to multiply and invade the salivary glands whilst the Choachi strain rapidly multiplied in the hemolymph to invade salivary glands. However, in insects inoculated with H14 strain, the levels of PPO and superoxide generated by R. prolixus were significantly higher than Choachi strain, and nitrite and nitrate levels were also much higher with H14 inoculations. Usually, short forms of epimastigotes stimulated greater superoxide and PPO reactions than long epimastigotes in both parasite strains in the hemolymph of R. prolixus. Furthermore, when the NADPH oxidase inhibitor, N-ethylmaleimide, or the inhibitor of the inducible nitric oxide synthase, S-methylisothiourea sulfamide, are injected into R. prolixus, they resulted in higher insect mortality after T. rangeli infection of either strains compared with those untreated controls [68]. Whitten et al. [75] demonstrated that the most pronounced reactions to crude LPS occurred in the R. prolixus fat body and hemocytes, while tissues of the digestive tract were most responsive to infections by T. cruzi and T. rangeli. This suggests that the NO-mediated immune responses in this insect are pathogen specific and independently modified both at the transcriptional and NO synthase gene expression.

            It is interesting to note that in a screening of R. prolixus genes activated after T. cruzi infection by sequencing of subtractive libraries, no genes related to the humoral immune response were found to be transcriptionally upregulated [76]. These results suggest that the R. prolixus immune responses to parasites are not mediated by AMPs, and could be centered in hemocytes nodulation, encapsulation and phagocytosis. The comparison between the responses against bacteria and T. cruzi also showed that R. prolixus activates different mechanisms of defence depending on the pathogen [77]. In this way, it is possible that the regulation of immune related genes in R. prolixus differs significantly after T. cruzi or T. rangeli infection.

            Hemocyte microaggregation and phagocytosis and T. rangeli infection: role of eicosanoids and PAF pathways

            The circulating hemocytes are essential for the insect immunity. In R. prolixus seven morphological hemocyte types were identified by phase-contrast microscopy: prohemocytes, granulocytes, plasmatocytes, cystocytes, oenocytes and adipohemocytes and giant cells [78]. Some cellular immune reactions have been studied in T. rangeli-triatomine interactions. Garcia et al. [29], demonstrated for the first time that eicosanoid biosynthesis inhibitors applied to R. prolixus strongly affect hemocyte microaggregation, one of the cellular immune reactions. The main data found by these authors were: (i) insects that had previously been fed on blood containing biosynthesis inhibitors of PLA2 (dexamethasone) and COX (indomethacin) and non-selective LOX inhibitor (nordihydroguaiaretic acid, NDGA) showed a significant increase in the number of free epimastigote forms of T. rangeli in the hemolymph and, consequently, increased lethality; and (ii) the parasite infection in insects treated with these compounds led to less hemocyte microaggregation and attenuated the activation of PPO system in the hemolymph.

            Garcia et al. [29] suggest that arachidonic acid was not available in insects treated with dexamethasone. Indeed, the application of arachidonic acid significantly enhanced both hemocyte microaggregation and PO activity in the hemolymph of insects previously treated with dexamethasone and challenged with parasites. It also reduced the number of parasites in the circulation and the mortality of insects. The effects of indomethacin and NDGA were considered relevant because they indicated the influence of multiple eicosanoid metabolites in immune reactions of R. prolixus infected with T. rangeli. Furthermore, hemocelic inoculation of epimastigotes of T. rangeli into larvae of R. prolixus previously fed with blood containing the same parasite, demonstrated a reduced number of hemocyte microaggregates, enhanced the number of parasites in the hemolymph as well as increased the mortality of these insects. All these effects were counteracted by combined injection of R. prolixus with T. rangeli and arachidonic acid [30]. These results suggest that the arachidonic acid pathway can be a mediator of hemocyte microaggregation reactions in the hemolymph of insects inoculated with T. rangeli and that oral infection with this protozoan inhibits the release of arachidonic acid (Figure 3).

            One interesting novelty of this parasite-vector interaction was revealed by Machado et al. [79]. They demonstrated that hemocelic injection of short T. rangeli epimastigotes in R. prolixus that were previously fed with blood containing WEB 2086 [a strong platelet-activating factor (2-acetyl-1-hexadecyl-sn-glycero-3-phosphocholine (PAF) antagonist] resulted in reduced hemocyte microaggregation, attenuated PPO activation in the hemolymph as well as increased the parasitemia and insect mortality. Nevertheless, simultaneous application of PAF did not counteract hemocytes microaggregation and PO activity.

            It was demonstrated that physalin B, a natural secosteroidal chemical from Physalis angulata, induces immunodepression in R. prolixus [8082] and strongly blocks hemocyte phagocytosis and microaggregate formations in R. prolixus [80]. The inhibition induced by physalin B was counteracted for both phagocytosis and microaggregation of hemocytes by arachidonic acid or PAF applied by hemocelic injection. Physalin B did not alter hemocyte PLA2 activities but it significantly enhanced PAF-acetyl hydrolase (PAF-AH) activity in the cell free hemolymph and hemocytes. Theses findings reinforce the importance of PAF and arachidonic acid pathways in cellular immune reactions in R. prolixus (Figure 3).

            The most exciting outcome in the investigation of T. rangeli in triatomines is the PAF influence on the hemocyte nodulation [79] and phagocytic responses of R. prolixus hemocytes against Saccharomyces cerevisiae [66, 67]. These authors evaluated the effects of PAF and eicosanoids in the phagocytosis in hemocyte monolayers (the main cell type implicated in this process is plasmatocytes) of R. prolixus against the yeast S. cerevisiae. The experiments demonstrated that the phagocytosis of yeast cells by Rhodnius hemocytes is very efficient in both controls and cells treated with PAF or arachidonic acid. However, phagocytosis of yeast particles is significantly diminished when the specific inhibitor of PLA2, dexamethasone, is applied to the hemocytes. By contrast, dexamethasone pre-treated hemocyte monolayers exhibit a drastic enhancement in the quantity of yeast cell-hemocyte internalizations when the cells are treated with arachidonic acid. Phagocytosis decreases expressively in hemocyte monolayers treated with WEB 2086, a specific PAF receptor antagonist. Nevertheless, a decrease of phagocytosis with WEB 2086 is also counteracted by the treatment with PAF [66, 67]. The authors suggest that these data on phagocytosis of yeast cells by hemocytes are related to the activation of PAF receptors and provides a novel insight into the cell signaling pathway of non-self recognition related to cellular immune reactions in the insect-parasite relationship.

            Finally, Figueiredo et al. [66] demonstrated that hemocyte phagocytosis was significantly reduced by oral infection with T. rangeli. These authors demonstrated that hemocyte phagocytosis inhibition caused by the parasite infection was rescued by exogenous arachidonic acid or PAF applied by hemocelic injection. They also observed an attenuation of PLA2 activities in R. prolixus hemocytes (cytosolic PLA2: cPLA2, secreted PLA2: sPLA2 and Ca++-independent PLA2: iPLA2) and an increase of sPLA2 in cell-free hemolymph. At the same time, the PAF-AH activity in the cell-free hemolymph enhanced considerably. These data suggest that T. rangeli infection depresses eicosanoids and insect PAF analogous (iPAF) pathways giving support to the role of PLA2 in the modulation of arachidonic acid and iPAF biosynthesis and of PAF-acetylhydrolase (PAF-AH) by reducing the concentration of iPAF in R. prolixus [67]. The relationship between the expression of the genes of PLA2 and PAF-AH as well as general cellular responses and signal transduction pathways is poorly understood in hemipterans. In this way, it is difficult to interpret the T. rangeli immunosuppression in terms of regulation of cellular signal transduction cascades. The data above suggest an inhibition of the NF-κB pathway, one well known effect of physalin treatment in mammal cells [82]. This is in agreement with the inhibition of the humoral immune response, but more detailed studies on the molecular mechanisms are needed to clarify this point.

            All these finding illustrate the ability of T. rangeli to modulate the cellular immune responses of R. prolixus to favor its own multiplication in the hemolymph.


            Interventions to study the triatomine vector biology may be useful to develop new concepts and means to block parasite transmission, both of which are urgent and necessary. The recent investigations into R. prolixus immune reactions relating to T. rangeli development have established a new conceptual hypothesis: a fine modulation of insect factors can interfere with parasite development and this is important for the establishment of infection, being an attractive target for intervention (Fig. 5).
            Figure 5

            A schematic illustration of Trypanosoma rangeli regulating the Rhodnius prolixus immune reactions. White arrows (↓) indicate immune reactions decrease after infection of R. prolixus with T. rangeli. In the case of AMP production by R. prolixus, there is no known (?) regulation by T. rangeli.

            Despite the progress in understanding the complexity of the insect immune responses, our knowledge of this theme in hemipteran vectors remains far from complete. Much work is still needed to understand the successful transmission of protozoans as the result of the immune modulation, as caused by T. rangeli infection in R. prolixus. It is necessary to understand humoral and hemocytes-surface receptors and regulators and intracellular signaling molecules to permit the development of new immunomodulatory drugs, designed to control vector insect's populations.

            Finally, another point to be considered is that for triatomines the limited use of molecular biology technology has permitted only a fragmented view of the immune defence system in this important Chagas disease vector. Moreover, advances in Rhodnius genomics and functional genomics in the near future will lead to a rapid development of this field. The study of genes involved in immune reactions will reinforce the need to better understand the defence responses related to parasite-vector interactions.



            Funding for this work was provided by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) to ESG and PA, Fundação Oswaldo Cruz (FIOCRUZ) (Papes Project to PA) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) to PA and FAG. ESG and PA are CNPq Senior Research Fellows. DPC is a post-doc researcher of FIOCRUZ and MBF is a post-graduate student from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). We thank Gutemberg Brito for R. prolixus picture used in Figure 5.

            Authors’ Affiliations

            Laboratório de Bioquímica e Fisiologia de Insetos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz


            1. Ashida M: The prophenoloxidase cascade in insect immunity. Res Immunol. 1990, 141 (9): 908-910. 10.1016/0923-2494(90)90191-Z.View ArticlePubMed
            2. Teixeira M, Almeida IV, Gazzinelli RT: Introduction: innate recognition of bacteria and protozoan parasites. Microbes Infect. 2002, 4: 883-886. 10.1016/S1286-4579(02)01625-8.View ArticlePubMed
            3. Maramaras VJ, Lampropoulou M: Regulators and signaling in insect haemocytes immunity. Cellular Signalling. 2009, 21: 186-195. 10.1016/j.cellsig.2008.08.014.View Article
            4. Lazzaro BP: Natural selection on the Drosophila antimicrobial immune system. Curr Opin Microbiol. 2008, 11: 284-289. 10.1016/j.mib.2008.05.001.PubMed CentralView ArticlePubMed
            5. Hoffmann JA: The immune response of Drosophila. Nature. 2003, 426: 33-38. 10.1038/nature02021.View ArticlePubMed
            6. Hoffmann JA, Reichhart JM: Drosophila innate immunity: an evolutionary perspective. Nat Immunol. 2002, 3: 121-126. 10.1038/ni0202-121.View ArticlePubMed
            7. Christophides GK, Vlachou D, Kafatos FC: Comparative and functional genomics of the innate immune system in the malaria vector Anophelis gambiae. Immunol Rev. 2004, 198: 127-148. 10.1111/j.0105-2896.2004.0127.x.View ArticlePubMed
            8. Bullet P, Dimarcq JL, Hoffmann D: Antimicrobial peptides in insects: structure and function. Dev Comp Immunol. 1999, 23: 329-344. 10.1016/S0145-305X(99)00015-4.View Article
            9. Tzou P, Ohresser S, Ferrandon D, Capovilla M, Reichhart JM, Lemaitre B, Hoffmann JA, Imler JL: Tissue-specific inducible expression of antimicrobial peptide genes in Drosophila surface epithelia. Immunity. 2000, 13: 737-748. 10.1016/S1074-7613(00)00072-8.View ArticlePubMed
            10. Dimarcq JL, Hoffmann D, Meister M, Bulet P, Lanot R, Reichhart JM, Hoffmann JA: Characterization and transcriptional profiles of a Drosophila gene encoding an insect defensin. A study in insect immunity. Eur J Biochem. 1994, 221: 201-209. 10.1111/j.1432-1033.1994.tb18730.x.View ArticlePubMed
            11. Kylsten P, Samakovlis C, Hultmark D: The cecropin locus in Drosophila : a compact gene cluster involved in the response to infection. EMBO J. 1990, 9: 217-224.PubMed CentralPubMed
            12. Hultmark D: Drosophila immunity: paths and patterns. Curr Opin Immunol. 2003, 15: 12-19. 10.1016/S0952-7915(02)00005-5.View ArticlePubMed
            13. Li J, Li W, Calhoun HC, Xia F, Gao FB, Li WX: Patterns and functions of STAT activation during Drosophila embryogenesis. Mech Devel. 2003, 120: 1455-1468. 10.1016/j.mod.2003.09.004.View Article
            14. Boutros M, Agaisse H, Perrimon N: Sequential activation of signaling pathways during innate responses in Drosophila. Dev Cell. 2002, 3: 711-722. 10.1016/S1534-5807(02)00325-8.View ArticlePubMed
            15. Cerenius L, Lee BL, Söderhäll K: The proPO-system: pros and cons for its role in invertebrate immunity. Trends Immunol. 2008, 29: 263-271. 10.1016/ ArticlePubMed
            16. Christensen BM, Li J, Chen CC, Nappi AJ: Melanization immune responses in mosquito vectors. Trends Parasitol. 2005, 21: 192-199. 10.1016/ ArticlePubMed
            17. Luckhart S, Vodovotz Y, Cui L, Rosenberg R: The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. PNAS USA. 1998, 95: 5700-5705. 10.1073/pnas.95.10.5700.PubMed CentralView ArticlePubMed
            18. Lavine MD, Strand MR: Insect hemocytes and their role in immunity. Insect Biochem Mol Biol. 2002, 32: 1295-1309. 10.1016/S0965-1748(02)00092-9.View ArticlePubMed
            19. Nappi AJ, Vass E: Hydrogen peroxide production in immunereactive Drosophila melanogaster. J Parasitol. 1998, 84: 1150-1157. 10.2307/3284664.View ArticlePubMed
            20. Lenine L: Arachidonate Metabolism in Immunologic System. 1988, Basel: Kagel
            21. Stanley DW: Eicosanoids in Invertebrate Signal Transduction Systems. 2000, Princeton: Princeton University Press
            22. Stanley DW: Prostaglandins and other eicosanoids in insects: biological significance. Ann Rev Entomol. 2006, 51: 25-44. 10.1146/annurev.ento.51.110104.151021.View Article
            23. Stanley-Samuelson DW, Jensen E, Nickerson KW, Tiebel K, Ogg CL, Howard RW: Insect immune response to bacterial infection is mediated by eicosanoids. PNAS USA. 1991, 88: 1064-1068. 10.1073/pnas.88.3.1064.PubMed CentralView ArticlePubMed
            24. Miller JS, Nguyen T, Stanely-Samuelson DW: Eicosanoids mediate insect nodulation response to bacterial infection. PNAS USA. 1994, 91: 12418-12422. 10.1073/pnas.91.26.12418.PubMed CentralView ArticlePubMed
            25. Mandato CA, Diehl-Jones WL, Moore SJ, Downer RGH: The effects of eicosanoid biosynthesis inhibitors on prophenoloxidase activation, phagocytosis and cell spreading in Galleria mellonella. J Insect Physiol. 1997, 43: 1-8. 10.1016/S0022-1910(96)00100-X.View ArticlePubMed
            26. Dean P, Gadsden JC, Richard EH, Edwards JP, Charnley AK, Reynolds SE: 2002. Modulation by eicosanoid biosynthesis inhibitors of immune responses by the insect Manduca sexta to the pathogenic fungus Metarhizium anisopliae. J Invertebr Pathol. 2002, 79 (2): 93-101. 10.1016/S0022-2011(02)00014-9.View ArticlePubMed
            27. Lord JC, Anderson S, Stanley DW: Eicosanoids mediate Manduca sexta cellular response to the fungal pathogen Beauveria bassiana: a role for the lipoxygenase pathway. Arch Insect Biochem Physiol. 2002, 51 (1): 46-54. 10.1002/arch.10049.View ArticlePubMed
            28. Carton Y, Frey F, Stanley DW, Vass E, Nappi AJ: Dexamethasone inhibition of the cellular immune response of Drosophila melanogaster against a parasitoid. J Parasitol. 2002, 88 (2): 405-407.View ArticlePubMed
            29. Garcia ES, Machado EMM, Azambuja P: Effects of eicosanoid biosynthesis inhibitors on the prophenol-activating system and microaggregate formation in Rhodnius prolixus infected with Trypanosoma rangeli. J Insect Physiol. 2004, 50: 157-165. 10.1016/j.jinsphys.2003.11.002.View ArticlePubMed
            30. Garcia ES, Machado EMM, Azambuja P: Inhibition of hemocyte microaggregation reactions in Rhodnius prolixus larvae orally infected with Trypanosoma rangeli. Exp Parasitol. 2004, 107: 31-38. 10.1016/j.exppara.2004.03.015.View ArticlePubMed
            31. Stanley DW, Shapiro M: Eicosanoid biosynthesis inhibitors increase the susceptibility of Lymantria dispar to nucleopolyhedrovirus LdMNPV. J Invertebr Pathol. 2007, 95: 119-124. 10.1016/j.jip.2007.02.002.View ArticlePubMed
            32. Durmos Y, Büyükgüzel E, Terzi B, Tunaz H, Stanley D, Büyükgüzel K: Eicosanoids mediate melanotic nodulation reactions to viral infection in larvae of the parasitic wasp, Pimpla turionellae. J Insect Physiol. 2008, 54: 17-24. 10.1016/j.jinsphys.2007.03.019.View Article
            33. Miller JS, Stanley DW: Eicosanoids mediate microaggregation reactions to bacterial challenge in isolated hemocyte preparations. J Insect Physiol. 2001, 47: 1409-1417. 10.1016/S0022-1910(01)00131-7.View ArticlePubMed
            34. Tunaz H, Park Y, Büyükgüzel K, Bedick JC, Nor Aliza AR, Stanley DW: Eicosanoids in insect immunity: bacterial infection stimulates hemocytic phospholipase A2 activity in tobacco hornworms. Arch Insect Biochem Physiol. 2003, 52: 1-6. 10.1002/arch.10056.View ArticlePubMed
            35. Park Y, Kim Y, Putnam SM, Stanley DW: The bacterium Xenorhabdus nematophila depresses nodulation reactions to infection by inhibiting eicosanoid biosynthesis in tobacco hornworms. Manduca sexta. 2003, 52: 71-80.
            36. Park Y, Kim Y, Stanley D: The bacterium Xenorhabdus nematophila inhibits phospholipase A2 from insect, prokaryote, and vertebrate sources. Naturwissenschaften. 2004, 91: 371-373. 10.1007/s00114-004-0548-2.PubMed
            37. Park Y, Kim Y, Tunaz H, Stanley DW: An entomopathogenic bacterium, Xenorhabdus nematophila, inhibits hemocytic phospholipase A2 (PLA2) in tobacco hornworms Manduca sexta. J Invertebr Pathol. 2004, 86: 65-71. 10.1016/j.jip.2004.05.002.View ArticlePubMed
            38. D'Alessandro A: Biology of Trypanosoma (Herpetosoma) rangeli Tejera. 1920. Biology of Kinetoplastida. Edited by: WHR Lumsden WHR. 1976, Evans DA: London: Academic Press, 1: 327-493.
            39. Guhl F, Vallejo A: Trypanosoma (Herpetosoma) rangeli Tejera, 1920 – An updated review. Mem Inst Oswaldo Cruz. 2003, 98: 435-442. 10.1590/S0074-02762003000400001.View ArticlePubMed
            40. Vallejo GA, Guhl F, Schaub GA: Triatomine-Trypanosoma cruzi/rangeli : vector-parasite interactions. Acta Trop. 2009, 110: 137-147. 10.1016/j.actatropica.2008.10.001.View ArticlePubMed
            41. Garcia ES, Azambuja P: Development and interactions of Trypanosoma cruzi within the insect vector. Parasitol Today. 1991, 7: 240-244. 10.1016/0169-4758(91)90237-I.View ArticlePubMed
            42. Garcia ES, Azambuja P: Infection of triatomines with Trypanosoma cruzi. Molecular Biology of Insect Disease Vectors: A Methods Manual. Edited by: Crampton JM, Beard CB, Louis C. 1997, London: Chapman and Hall, 46-155.
            43. Kollien AH, Schaub GA: The development of Trypanosoma cruzi in triatominae. Parasitol Today. 2000, 16: 381-387. 10.1016/S0169-4758(00)01724-5.View ArticlePubMed
            44. Garcia ES, Ratcliffe NA, Whitten MM, Gozalez MS, Azambuja P: Exploring the role of insect host factors in the dynamics of Trypanosoma cruziRhodnius prolixus interactions. J Insect Physiol. 2007, 53: 11-21. 10.1016/j.jinsphys.2006.10.006.View ArticlePubMed
            45. Oliveira MA, de Souza W: An electron microscopic study on penetration of Trypanosoma rangeli into the midgut cells of Rhodnius prolixus. J Invertebr Pathol. 2001, 77: 22-26. 10.1006/jipa.2000.4988.View ArticlePubMed
            46. Mello CB, Garcia ES, Ratcliffe NA, Azambuja P: Trypanosoma cruzi and Trypanosoma rangeli: interplay with hemolymph components of Rhodnius prolixus. J Invertebr Pathol. 1995, 65: 261-268. 10.1006/jipa.1995.1040.View ArticlePubMed
            47. Basseri HR, Tew IF, Ratcliffe NA: 2002. Identification and distribution of carbohydrate moieties on the salivary glands of Rhodnius prolixus and their possible involvement in attachment/invasion by Trypanosoma rangeli. Exp Parasitol. 2002, 100: 226-234. 10.1016/S0014-4894(02)00026-7.View ArticlePubMed
            48. Takle GB: Studies on the cellular immune response of insects toward the insect pathogen Trypanosoma rangeli. J Invertebr Pathol. 1988, 51: 64-72. 10.1016/0022-2011(88)90089-4.View ArticlePubMed
            49. Hecker H, Schwarzenbach M, Rudin W: Development and interactions of Trypanosoma rangeli in and with the reduviid bug, Rhodnius prolixus. Parasitol Res. 1990, 76 (4): 11-318. 10.1007/BF00928185.View Article
            50. Garcia ES, Mello CB, Azambuja P, Ribeiro JMC: Rhodnius prolixus : salivary anti-hemostatic components decrease with Trypanosoma rangeli infection. Exp Parasitol. 1994, 78: 287-293. 10.1006/expr.1994.1030.View ArticlePubMed
            51. Ribeiro JM, Schneider M, Isaias T, Jurberg J, Galvão C, Guimarães J: Role of salivary antihemostatic components in blood feeding by triatomine bugs (Heteroptera). J Med Entomol. 1998, 35: 599-610.View ArticlePubMed
            52. Tobie EJ: Observation on the development of Trypanosoma rangeli in the hemocoel of Rhodnius prolixus. J Invertebr Pathol. 1970, 16: 118-125. 10.1016/0022-2011(70)90106-0.View Article
            53. Azambuja P, Garcia ES: Care and maintenance of triatomines colonies. Molecular Biology of Insect Disease Vectors: A Methods Manual. Edited by: Crampton JM, Beard CB, Louis C. 1997, London: Chapman and Hall, 56-64. 1View Article
            54. Wigglesworth VB: The Principles of Insect Physiology. 1972, London: Chapman and Hall
            55. Davey KG: The physiology of reproduction in Rhodnius and other insects. Insect Biology in the Future "VBW 80". Edited by: Locke M, Smith DS. 1980, New York: Academic Press, 325-344.
            56. Huebner E: The Rhodnius Genome Project: The promises and challenges it affords in our understanding of reduviid biology and their role in Chagas' transmission. Comp Biochem Physiol – Part A: Mol Integ Physiol. 2007, 148 (Suppl 1): S130-10.1016/j.cbpa.2007.06.325.View Article
            57. Nogueira NFS, Gonzalez MS, Garcia ES, de Souza W, Azambuja P: Effect of azadirachtin A on the fine structure of the midgut of Rhodnius prolixus. J Invertebr Pathol. 1997, 69: 58-63. 10.1006/jipa.1996.4635.View ArticlePubMed
            58. Cortez M, Gonzalez MS, Cabral MM, Garcia ES, Azambuja A: Dynamic development of Trypanosoma cruzi in Rhodnius prolixus: role of decapitation and ecdysone therapy. Parasitol Res. 2002, 88: 697-703.View ArticlePubMed
            59. Alves C, Albuquerquer-Cunha JM, Mello C, Garcia ES, Nogueira N, Bourguingnon S, de Souza W, Azambuja P, Gonzalez MS: Trypanosoma cruzi : Attachment to perimicrovillar membrane glycoproteins of Rhodnius prolixus. Exp Parasitol. 2007, 116: 44-52. 10.1016/j.exppara.2006.11.012.View ArticlePubMed
            60. Azambuja P, Feder D, Garcia ES: Isolation of Serratia marcescens in the midgut of Rhodnius prolixus: impact on the establishment of the parasite Trypanosoma cruzi in the vector. Exp Parasitol. 2004, 107: 89-96. 10.1016/j.exppara.2004.04.007.View ArticlePubMed
            61. Azambuja P, Garcia ES, Ratcliffe NA: Gut microbiota and parasite transmission by insect vectors. Trends Parasitol. 2005, 21: 568-572. 10.1016/ ArticlePubMed
            62. Azambuja P, Guimarães JA, Garcia ES: Haemolytic factor from the crop of Rhodnius prolixus : evidence and partial characterization. J Insect Physiol. 1983, 11: 833-837. 10.1016/0022-1910(83)90149-X.View Article
            63. Ratcliffe NA, Nigam Y, Mello CB, Garcia ES, Azambuja P: Trypanosoma cruzi and erythrocyte agglutinins: A comparative study of occurrence and properties in the gut and hemolymph of Rhodnius prolixus. Exp Parasitol. 1996, 83: 83-93. 10.1006/expr.1996.0052.View ArticlePubMed
            64. Gomes SAO, Feder D, Garcia ES, Azambuja P: Suppression of the prophenoloxidase system in Rhodnius prolixus orally infected with Trypanosoma rangeli. J Insect Physiol. 2003, 49: 829-837. 10.1016/S0022-1910(03)00133-1.View ArticlePubMed
            65. Figueiredo MB, Castro D, Nogueira N, Garcia ES, Azambuja P: Cellular immune response in Rhodnius prolixus : Role of ecdysone in hemocyte phagocytosis. J Insect Physiol. 2006, 52: 711-716. 10.1016/j.jinsphys.2006.03.011.View ArticlePubMed
            66. Figueiredo MB, Garcia ES, Azambuja P: Blockades of phospholipase A2 and platelet-activating factor receptors reduce the hemocyte phagocytosis in Rhodnius prolixus : In vitro experiments. J Insect Physiol. 2008, 54: 344-350. 10.1016/j.jinsphys.2007.10.004.View ArticlePubMed
            67. Figueiredo MB, Genta F, Garcia ES, Azambuja P: Lipid mediators and vector infection: Trypanosoma rangeli inhibits Rhodnius prolixus hemocyte phagocytosis by modulation of phospholipase A2 and PAF-acetylhydrolase activities. J Insect Physiol. 2008, 54: 1528-1537. 10.1016/j.jinsphys.2008.08.013.View ArticlePubMed
            68. Whitten MM, Mello CB, Gomes SAO, Nigam Y, Azambuja P, Garcia ES, Ratcliffe NA: Role of superoxide and reactive nitrogen intermediates in Rhodnius prolixus (Reduviidae)/Trypanosoma rangeli interactions. Exp Parasitol. 2001, 98: 44-57. 10.1006/expr.2001.4615.View ArticlePubMed
            69. Lopez L, Morales G, Ursic R, Lowenberguer C: Isolation and characterization of a novel defensin from Rhodnius prolixus, a vector of Chagas disease. Insect Biochem Mol Biol. 2003, 33 (4): 437-447. 10.1016/S0965-1748(03)00008-0.View Article
            70. Mello CB, Nigam Y, Garcia ES, Azambuja P, Newton RP, Ratcliffe NA: Studies of a hemolymph lectin isolated from Rhodnius prolixus and its interaction with Trypanosoma rangeli. Exp Parasitol. 1999, 91: 89-296. 10.1006/expr.1998.4385.View Article
            71. Gregorio EA, Ratcliffe NA: The distribution of agglutinins and lytic activity against Trypanosoma rangeli and erythrocytes in Rhodnius prolixus and Triatoma infestans tissue extracts and haemolymph. Mem Inst Oswaldo Cruz. 1991, 86: 181-186. 10.1590/S0074-02761991000200007.View ArticlePubMed
            72. Gregorio EA, Ratcliffe NA: The prophenoloxidase system and in vitro interaction of Trypanosoma rangeli with Rhodnius prolixus and Triatoma infestans haemolymph. Parasite Immunol. 1991, 13: 551-564. 10.1111/j.1365-3024.1991.tb00551.x.View ArticlePubMed
            73. Gomes SAO, Feder D, Thomas NE, Garcia ES, Azambuja P: Rhodnius prolixus infected with Trypanosoma rangeli: in vivo and in vitro experiments. J Invertebr Pathol. 1999, 73: 289-293. 10.1006/jipa.1998.4836.View ArticlePubMed
            74. Gomes SAO, Almeida IC, Oliveira MF, Garcia ES, Azambuja P: Prophenoloxidase activation by Trypanosoma rangeli in Rhodnius prolixus: effects of membrane components isolated from short and long epimastigotes. Soc Brasil Protozool. 2001, 1: 47-48.
            75. Whitten MM, Sun F, Tew I, Schaub GA, Soukou C, Nappi A, Ratcliffe NA: Differential modulation of Rhodnius prolixus nitric oxide activities following challenge with Trypanosoma rangeli, T. cruzi and bacterial cell wall components. Insect Biochem Mol Biol. 2007, 37: 440-452. 10.1016/j.ibmb.2007.02.001.View ArticlePubMed
            76. Ursic-Bedoya RJ, Lowenberger CA: Rhodnius prolixus: identification of immune-related genes up-regulated in response to pathogens and parasites using suppressive subtractive hybridization. Dev Comp Immunol. 2007, 31: 109-120. 10.1016/j.dci.2006.05.008.View ArticlePubMed
            77. Vanderberghe I, Creancier L, Vispé S, Annereau JP, Barret JM, Porny L, Samson A, Aussagues Y, Massiot G, Ausseil F, Bailly C, Kruczinsky A: Physalin B a noble inhibitor of the ubiquitin-proteosome pathway, triggers NOXA-associated apoptosis. Biochem Pharmacol. 2008, 76: 453-462. 10.1016/j.bcp.2008.05.031.View Article
            78. Azambuja P, Garcia ES, Ratcliffe NA: Aspects of classification of Hemiptera hemocytes from six triatomine species. Mem Inst Oswaldo Cruz. 1991, 86: 1-10.View ArticlePubMed
            79. Machado EM, Azambuja P, Garcia ES: WEB a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and hemocyte microaggregation reactions induced by Trypanosoma rangeli infection in Rhodnius prolixus hemolymph. J Insect Physiol. 2086, 52 (7): 685-692. 10.1016/j.jinsphys.2006.03.008.View Article
            80. Garcia ES, Castro DP, Ribeiro IM, Tomassini TC, Azambuja P: Trypanosoma rangeli : effects of physalin B on the immune reactions of the infected larvae of Rhodnius prolixus. Exp Parasitol. 2006, 112: 37-43. 10.1016/j.exppara.2005.09.003.View ArticlePubMed
            81. Castro DP, Figueiredo MB, Ribeiro IM, Tomassini TC, Azambuja P, Garcia ES: Immune depression in Rhodnius prolixus by seco-steroids, physalins. J Insect Physiol. 2008, 54: 555-562. 10.1016/j.jinsphys.2007.12.004.View ArticlePubMed
            82. Castro DP, Figueiredo MB, Genta FA, Ribeiro IM, Tomassini TC, Azambuja P, Garcia ES: Physalin B inhibits Rhodnius prolixus hemocyte phagocytosis and microaggregation by the activation of endogenous PAF-acetyl hydrolase activities. J Insect Physiol. 2009, 55: 532-537. 10.1016/j.jinsphys.2009.01.013.View ArticlePubMed


            © Garcia et al; licensee BioMed Central Ltd. 2009

            This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.